#InvestorIdeas Adds #Technology and #Biotech
#Stocks ($INSY, $CTBO and $EBIO) to Directories
Technology Stock
Additions Include: TSX Venture: $AKR.V, $BPL.V, $MKT.V, $EQ.V, $FSW.V, $KBY.V,
$AT.V, $BKD.V, $BTL.V, $DXX.V, $MVP.V, $MBO.V, $MV.V, $PGV.V, $PFM.V
Point Roberts, WA, Delta BC – July 8, 2016 –
Investorideas.com, a global news source and investor resource covering actively
traded sectors announces this week’s additions to its global stock
directories. Additions are mainly within
the technology sector, with a focus on TSX Venture Exchange Traded Stocks.
Also added are three biotech companies - INSYS
Therapeutics, Inc. (NasdaqGM: INSY) focused on novel drug delivery systems
and treating addiction to opioids, opioid overdose and epilepsy; Cantabio Pharmaceuticals Inc. (OTC:CTBO) which is
focusing on protein systems implicated in neurodegenerative disorders,
including Alzheimer’s, Parkinson’s and oxidative stress; and Eleven Biotherapeutics, Inc. (NasdaqGM:EBIO) which focuses on the discovery and
development of protein therapeutics to treat diseases of the eye.
Investorideas.com global stock directories are part
of the membership program on the site, accessed either by login and password or
available in PDF format. The directories
include stocks trading on the TSX, OTC, NASDAQ, NYSE and other recognized
global stock exchanges, giving retail investors a wide variety of stocks to
review. http://www.investorideas.com/membership/
The directories are not meant as recommendations
but as a research tool to discover opportunities and trading ideas in a
particular sector.
Tech Companies Added: Ackroo Inc. (TSX:AKR.V), Bluedrop Performance Learning Inc (TSX:BPL.V), DeepMarkit
Corp. (TSX:MKT.V), EQ
Inc. (TSX:EQ.V), Fireswirl Technologies
Inc (TSX:FSW.V), Kona
Bay Technologies Inc. (TSX:KBY.V), AcuityAds Holdings Inc
(TSX: AT.V), Breaking Data Corp. (TSX:BKD.V), BTL
Group Ltd (TSX:BTL.V), DXStorm.com Inc (TSX:DXX.V), MediaValet Inc (TSX:MVP.V), Mobio Technologies Inc. (TSX:MBO.V), MOVIT Media Corp. (TSX:MV.V), Prodigy Ventures Inc (TSX:PGV.V) and ProntoForms Corporation (TSX:PFM.V).
Biotech:
INSYS Therapeutics, Inc. (NasdaqGM: INSY) is a specialty pharmaceutical company
that develops and commercializes innovative drugs and novel drug delivery
systems of therapeutic molecules that improve the quality of life of patients.
Using proprietary sublingual spray technology and capabilities to develop
pharmaceutical cannabinoids, Insys addresses the clinical shortcomings of
existing commercial products. Insys currently markets one product, Subsys® (fentanyl sublingual
spray) but has received approval for the marketing of Syndros™ (dronabinol oral
solution), a proprietary, orally administered liquid formulation of dronabinol
that Insys believes has distinct advantages over the current formulation of
dronabinol in soft gel capsule. Insys is developing a pipeline of sublingual
sprays, as well as pharmaceutical cannabidiol. Insys is committed to developing
medications for potentially treating addiction to opioids, opioid overdose,
epilepsy and other disease areas with high unmet need. Subsys® and Syndros™ are trademarks of Insys
Therapeutics, Inc.
Cantabio Pharmaceuticals Inc. (OTC:CTBO) is focused on bringing novel, first in class drug
candidates into clinical trials and beyond through the discovery and development
of innovative pharmacological chaperone and protein delivery based
therapeutics, focusing on protein systems implicated in neurodegenerative
disorders, including Alzheimer’s and Parkinson’s, and oxidative stress.
Eleven
Biotherapeutics, Inc. (NasdaqGM:EBIO) is
a preclinical-stage biopharmaceutical company with a proprietary protein
engineering platform, called AMP-Rx, that it applies to the discovery and
development of protein therapeutics to treat diseases of the eye. Eleven’s
therapeutic approach is based on the role of cytokines in diseases of the eye,
the Company’s understanding of the structural biology of cytokines and the
Company’s ability to rationally design and engineer proteins to modulate the
effects of cytokines. Cytokines are cell signaling molecules found in the body
that can have important inflammatory effects.
About Investorideas.com - News that Inspires Big Ideas
Sectors we cover in include mining, energy,
renewable energy, water stocks, food and beverage (including organic and LOHAS,
wine), defense and security, biotech, technology and mobile. We have also
expanded our global coverage to include Latin American stocks, the Middle East,
sports and entertainment.
Investor Ideas Directories for global investors:
From water stocks to gold and mining stocks,
renewable energy, nanotech, defense, technology, biotech and more – use our
stock directories and access them online 24/7 with login as a member to find
your next big idea!
Disclaimer/Disclosure:
Investorideas.com is a digital publisher of third party sourced news, articles
and equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info regarding BC Residents and global
Investors: Effective September 15 2008 - all BC investors should review all OTC
and Pink sheet listed companies for adherence in new disclosure filings and
filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to
regulations of each country.
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment